... by Amgen in 2008 and it is a biologic drug which is developed by the complex genetic engineering process of recombinant DNA technology.
https://www.google.com/url?rct=j&sa=t&url=https://www.financialexpress.com/lifestyle/health/enzene-gets-dcgi-nod-for-biosimilar-drug-to-treat-haematological-disorder/2330253/&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNH2N8MNHl4fteBgY9hlqK-8aVzdCA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.